ZA918489B - Method for making liposomes of enhanced entrapping capacity toward foreign substances to be encapsulated - Google Patents

Method for making liposomes of enhanced entrapping capacity toward foreign substances to be encapsulated

Info

Publication number
ZA918489B
ZA918489B ZA918489A ZA918489A ZA918489B ZA 918489 B ZA918489 B ZA 918489B ZA 918489 A ZA918489 A ZA 918489A ZA 918489 A ZA918489 A ZA 918489A ZA 918489 B ZA918489 B ZA 918489B
Authority
ZA
South Africa
Prior art keywords
pct
encapsulated
enhanced
foreign substances
making liposomes
Prior art date
Application number
ZA918489A
Other languages
English (en)
Inventor
Michel Schneider
Schneider Michel
Harve Tournier
Tournier Harve
Roland Hyacinthe
Hyacinthe Roland
Christian Guillot
Guillot Christian
Berhard Lamy
Lamy Berhard
Original Assignee
Sint Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sint Sa filed Critical Sint Sa
Publication of ZA918489B publication Critical patent/ZA918489B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA918489A 1990-12-11 1991-10-24 Method for making liposomes of enhanced entrapping capacity toward foreign substances to be encapsulated ZA918489B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90810969 1990-12-11

Publications (1)

Publication Number Publication Date
ZA918489B true ZA918489B (en) 1992-07-29

Family

ID=8205973

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA918489A ZA918489B (en) 1990-12-11 1991-10-24 Method for making liposomes of enhanced entrapping capacity toward foreign substances to be encapsulated

Country Status (20)

Country Link
US (1) US5393530A (el)
EP (1) EP0514523B1 (el)
JP (1) JP3241720B2 (el)
KR (1) KR0137783B1 (el)
AT (1) ATE131724T1 (el)
AU (1) AU635456B2 (el)
CA (1) CA2072559C (el)
DE (1) DE69115682T2 (el)
DK (1) DK0514523T3 (el)
ES (1) ES2081605T3 (el)
GR (1) GR3018506T3 (el)
HU (1) HUT62458A (el)
IE (1) IE72163B1 (el)
IL (1) IL99835A (el)
IN (1) IN172269B (el)
IS (1) IS1685B (el)
MX (1) MX9102516A (el)
NZ (1) NZ240817A (el)
WO (1) WO1992010166A1 (el)
ZA (1) ZA918489B (el)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5469854A (en) * 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5542935A (en) * 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5352435A (en) * 1989-12-22 1994-10-04 Unger Evan C Ionophore containing liposomes for ultrasound imaging
US5874062A (en) 1991-04-05 1999-02-23 Imarx Pharmaceutical Corp. Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
JPH08505312A (ja) * 1992-10-16 1996-06-11 ザックセ，アンドレアス 液状分散系を製造する方法及び装置
US5869305A (en) * 1992-12-04 1999-02-09 The University Of Pittsburgh Recombinant viral vector system
US6217849B1 (en) 1993-09-29 2001-04-17 Bracco Research S.A. Liposome suspensions as blood pool imaging contrast agents
CA2185810A1 (en) * 1994-03-28 1995-10-05 Jo Klaveness Liposomes
AU4546996A (en) * 1995-02-24 1996-09-11 Bracco Research S.A. Liposome suspensions as blood pool imaging contrast agents
US5738868A (en) * 1995-07-18 1998-04-14 Lipogenics Ltd. Liposome compositions and kits therefor
US6447800B2 (en) 1996-01-18 2002-09-10 The University Of British Columbia Method of loading preformed liposomes using ethanol
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US20010051131A1 (en) * 1996-06-19 2001-12-13 Evan C. Unger Methods for delivering bioactive agents
DE19639811A1 (de) * 1996-09-27 1998-04-02 Artur Herzog Dr Mesmer Verwendung einer Liposomenlösung zur Verstärkung der Wirksamkeit und/oder Verminderung der Toxizität von Arzneimitteln
GB9624918D0 (en) * 1996-11-29 1997-01-15 Nycomed Imaging As Particulate components
WO1998044910A1 (en) 1997-04-09 1998-10-15 Philipp Lang NEW TECHNIQUE TO MONITOR DRUG DELIVERY NONINVASIVELY $i(IN VIVO)
DE19731591C2 (de) * 1997-07-17 1999-09-16 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylgruppenhaltige Trijodaromaten und ihre Verwendung in der Tumortherapie und interventionellen Radiologie
US6106858A (en) * 1997-09-08 2000-08-22 Skyepharma, Inc. Modulation of drug loading in multivescular liposomes
US6306432B1 (en) * 1997-09-08 2001-10-23 Chiron Corporation High and low load formulations of IGF-I in multivesicular liposomes
JP4467789B2 (ja) 1997-09-18 2010-05-26 パシラ ファーマシューティカルズ インコーポレーテッド 持続放出性リポソーム麻酔組成物
IL135989A0 (en) 1997-11-14 2001-05-20 Skyepharma Inc Processes for the production of multivesicular liposomes
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE19813773A1 (de) * 1998-03-27 1999-09-30 Clemens Unger Verfahren zur Herstellung von liposomalen Wirkstoffformulierungen
AU752225B2 (en) 1998-07-17 2002-09-12 Pacira Pharmaceuticals, Inc. Biodegradable compositions for the controlled release of encapsulated substances
US6511676B1 (en) 1999-11-05 2003-01-28 Teni Boulikas Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
EP1289565B1 (en) 2000-06-02 2015-04-22 Bracco Suisse SA Compounds for targeting endothelial cells
DE10121903A1 (de) * 2001-04-27 2002-10-31 Nimbus Biotechnologie Gmbh System für die Membranpermeationsmessung
AU2002322024B2 (en) * 2001-05-31 2008-05-08 Pacira Pharmaceuticals, Inc. Encapsulation of nanosuspensions in liposomes and microspheres
JP3990880B2 (ja) * 2001-07-10 2007-10-17 キヤノン株式会社 ポリヒドロキシアルカノエート被覆リポソームの製造方法
KR100521526B1 (ko) * 2001-07-10 2005-10-13 캐논 가부시끼가이샤 폴리하이드록시알카노에이트로 이루어진 입상 구조체 및그 제조방법
US20050118249A1 (en) * 2001-11-13 2005-06-02 Murray Webb Lipid carrier compositions and methods for improved drug retention
US8518437B2 (en) 2001-11-13 2013-08-27 Celator Pharmaceuticals, Inc. Lipid carrier compositions with enhanced blood stability
US20030129224A1 (en) * 2001-11-13 2003-07-10 Paul Tardi Lipid carrier compositions and methods for improved drug retention
US20050129750A1 (en) * 2003-12-15 2005-06-16 Yu-Fang Hu Process for producing liposome suspension and product containing liposome suspension produced thereby
EP1547582A1 (en) * 2003-12-23 2005-06-29 MediGene Oncology GmbH Method of producing lipid complexed camptothecin-carboxylate
EP1547580A1 (en) * 2003-12-23 2005-06-29 MediGene Oncology GmbH Loading of a camptothecin drug into colloidal nanoparticles
JP4773430B2 (ja) 2004-06-03 2011-09-14 ブラッコ・リサーチ・ソシエテ・アノニム 治療および／または診断用途のためのリポソーム集合体
ATE401057T1 (de) * 2004-10-08 2008-08-15 Alza Corp Verfahren zur einführung eines lipid-verknüpften teils in eine vorgeformte lipidanordnung mit mikrowellen
CA2595731A1 (en) * 2005-01-26 2006-08-03 Celator Pharmaceuticals, Inc. Lipid carrier compositions with reduced polydispersity
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
ES2275443B1 (es) 2005-11-30 2008-06-01 Italfarmaco, S.A. Procedimiento de preparacion de liposomas.
JP5080779B2 (ja) * 2006-10-25 2012-11-21 テルモ株式会社 リポソーム製剤の製造方法
US20110059549A1 (en) * 2007-05-09 2011-03-10 Coleman Matthew A Methods and systems for producing nanolipoprotein particles
WO2009067203A1 (en) * 2007-11-19 2009-05-28 Ceramoptec Industries, Inc. Pegylated compounds for age-related macular degeneration
US8907061B2 (en) * 2008-01-11 2014-12-09 Lawrence Livermore National Security, Llc. Nanolipoprotein particles and related methods and systems for protein capture, solubilization, and/or purification
US9303273B2 (en) 2008-05-09 2016-04-05 Lawrence Livermore National Security, Llc Nanolipoprotein particles comprising a natural rubber biosynthetic enzyme complex and related products, methods and systems
US8883729B2 (en) * 2008-05-22 2014-11-11 Lawrence Livermore National Security, Llc Nanolipoprotein particles and related compositions, methods and systems
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
CN102202694B (zh) 2008-10-07 2014-03-12 博莱科瑞士股份有限公司 包含抗-聚合物抗体的靶向构建体和结合它们的脂质体或微泡
EP2184054A1 (en) * 2008-11-08 2010-05-12 Lipoxen Technologies Limited Small Interfering RNA Delivery
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
EP2480209A1 (en) 2009-09-23 2012-08-01 Indu Javeri Methods for the preparation of liposomes comprising docetaxel
WO2012097346A1 (en) 2011-01-13 2012-07-19 Variation Biotechnologies, Inc. Compositions and methods for treating viral infections
US9644038B2 (en) 2011-12-21 2017-05-09 The Regents Of The University Of California Apolipoprotein nanodiscs with telodendrimer
EP2802353A4 (en) 2012-01-12 2015-12-02 Variation Biotechnologies Inc COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
RU2698906C2 (ru) * 2012-01-27 2019-09-02 Вэриэйшн Биотекнолоджиз, Инк. Способы и композиции для терапевтических агентов
MX364310B (es) * 2013-11-05 2019-04-22 Gustavo A Garcia Sanchez Método para preparar una formulación inmunosupresora.
WO2015166987A1 (ja) * 2014-04-30 2015-11-05 富士フイルム株式会社 リポソーム組成物及びその製造方法
DK3138555T3 (da) 2014-04-30 2020-12-14 Fujifilm Corp Liposomsammensætning og fremgangsmåde til fremstilling heraf
WO2016049061A1 (en) 2014-09-22 2016-03-31 Lawrence Livermore National Security, Llc Electrochemical flow-cell for hydrogen production and nicotinamide co-factor dependent target reduction, and related methods and systems
IL296875A (en) 2014-12-31 2022-12-01 Lantheus Medical Imaging Inc Fat-wrapped gas microsphere preparations and related methods
EP3291797B1 (en) 2015-05-04 2020-09-02 Versantis AG Method for preparing transmembrane ph-gradient vesicles
US11279749B2 (en) 2015-09-11 2022-03-22 Lawrence Livermore National Security, Llc Synthetic apolipoproteins, and related compositions methods and systems for nanolipoprotein particles formation
JP6564873B2 (ja) * 2015-11-02 2019-08-21 富士フイルム株式会社 リポソーム組成物およびその製造方法
EP3452108A4 (en) 2016-05-04 2019-12-25 Lantheus Medical Imaging, Inc. METHODS AND DEVICES FOR PREPARING ULTRASONIC CONTRAST AGENTS
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents
WO2018204421A2 (en) 2017-05-02 2018-11-08 Lawrence Livermore National Security, Llc Momp telonanoparticles, and related compositions, methods and systems
US12083223B2 (en) 2017-05-02 2024-09-10 Lawrence Livermore National Security, Llc Nanolipoprotein particles and related compositions methods and systems for loading RNA
CN114728101B (zh) * 2019-06-28 2023-07-14 德州大学系统董事会 重构脂质体安那霉素的方法
US11980636B2 (en) 2020-11-18 2024-05-14 Jazz Pharmaceuticals Ireland Limited Treatment of hematological disorders
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
CA1270198A (en) * 1984-08-08 1990-06-12 Marcel B. Bally Encapsulation of antineoplastic agents in liposomes
JPS6150912A (ja) * 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法
JPS63211222A (ja) * 1987-02-27 1988-09-02 Terumo Corp リポソ−ムの製法
US4963297A (en) * 1987-12-22 1990-10-16 The Liposome Company, Inc. Spontaneous vesticulation of multilamellar liposomes
CH672733A5 (el) * 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
US4870160A (en) * 1987-08-19 1989-09-26 Regents Of The University Of Minnesota Polypeptides with laminin activity
IE63518B1 (en) * 1987-11-18 1995-05-03 Vestar Inc Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
CA1330199C (en) * 1987-12-22 1994-06-14 Thomas D. Madden Spontaneous vesiculation of multilamellar liposomes
WO1989011272A1 (en) * 1988-05-20 1989-11-30 The Liposome Company, Inc. High ratio active agent:lipid complex
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release

Also Published As

Publication number Publication date
IL99835A0 (en) 1992-08-18
CA2072559C (en) 1997-03-18
HUT62458A (en) 1993-05-28
MX9102516A (es) 1992-06-01
AU9062991A (en) 1992-07-08
KR0137783B1 (ko) 1998-05-15
ATE131724T1 (de) 1996-01-15
IN172269B (el) 1993-05-29
NZ240817A (en) 1993-01-27
IL99835A (en) 1995-11-27
CA2072559A1 (en) 1992-06-12
EP0514523A1 (en) 1992-11-25
EP0514523B1 (en) 1995-12-20
GR3018506T3 (en) 1996-03-31
KR920703014A (ko) 1992-12-17
AU635456B2 (en) 1993-03-18
IS3773A7 (is) 1992-06-12
DE69115682T2 (de) 1996-05-15
IE72163B1 (en) 1997-03-26
IE914289A1 (en) 1992-06-17
WO1992010166A1 (en) 1992-06-25
DE69115682D1 (de) 1996-02-01
IS1685B (is) 1998-02-24
JP3241720B2 (ja) 2001-12-25
JPH05504150A (ja) 1993-07-01
ES2081605T3 (es) 1996-03-16
DK0514523T3 (da) 1996-01-29
US5393530A (en) 1995-02-28

Similar Documents

Publication Publication Date Title
ZA918489B (en) Method for making liposomes of enhanced entrapping capacity toward foreign substances to be encapsulated
PL339768A1 (en) Method of encapsulating aromatic and taste giving substances by controllable delivery of water into microcapsules
EP0140085A3 (en) Drug-containing lipid vesicle preparation and method for preparing them
CA2177695A1 (en) Method of transmitting a biologically active material to a cell
NO901852L (no) Fremgangsmaate for fremstilling av liposomer.
GB2015464B (en) Method of encapsulating biologically active materials in lipid vesicles
NZ241373A (en) Antigen-presenting chimaeric protein comprising the coat protein of ms-2 phage containing a foreign epitope in the beta-hairpin region
IE830690L (en) Stable plurilamellar vesicles
ES8608898A1 (es) Un dispositivo de liberacion de farmacos para inclusion en un sistema de suministro de farmacos por via parenteral
NZ503293A (en) Liposomal camptothecin formulations also comprising at least one phospholipid
DE3476338D1 (en) Preparation of unilamellar large diameter liposomes, their pharmaceutical application in view of the encapsulation of the active principle for sustained release, and device therefor
ATE150735T1 (de) Lagerstabil verkapseltes natriumpercarbonat und verfahren zu seiner herstellung
AU3102784A (en) Low temperature, storage stable mixtures of prepolymers and flow modifiers
SI0948319T1 (en) Encapsulated cells producing antibodies
EP0800822A3 (en) Method for preparing closed vesicles by rehydration of dehydrated vesicles
Kallenbach Fine structure of the stratum intermedium, stellate reticulum, and outer enamel epithelium in the enamel organ of the kitten.
HU9502855D0 (en) Method of encapsulating substances in biocapsules
Kasatkin State of Yb impurities in InP crystals.
DE69018258D1 (de) Aktive Bestandteile enthaltende phospholipidische Liposome und Verfahren zu ihrer Herstellung.
WO1990010436A3 (en) Membrane encapsulated essential oil
GB9225588D0 (en) Improving effectiveness of drugs
VINSON a) Biosystematics and Genetics b) Host relations and Biology c) Physiology and behaviour d) Ecology and Population Dynamics e) Rearing (in vivo & in vitro), Production and Release
FR2579589B1 (fr) Produit du type suspension contenant notamment du petit lait concentre, pour regler la croissance et le developpement des plantes
HU885490D0 (en) Process for producing plasminogeous activator from cells bred in lactine containing fodder medium
Grinberg The Parameters Characterising the Kinetics of Solution of Crystalline Germanium in a Germanium--Gold Solution-Melt System